KERRI PATTON: Open Payments
NPI 1457303653 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,252 in 63 payments from 15 companies in 2025. Trend: 2023 $176 · 2024 $377 · 2025 $1,252
Food & beverage: $1,252
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $199 |
| Otsuka America Pharmaceutical, Inc. | 14 | $181 |
| Corium, LLC | 6 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $119 |
| Axsome Therapeutics, Inc. | 5 | $103 |
| Lundbeck LLC | 4 | $99 |
| Vanda Pharmaceuticals Inc. | 4 | $92 |
| Janssen Pharmaceuticals, Inc | 4 | $76 |
| MDD US Operations, LLC | 3 | $60 |
| Collegium Pharmaceutical, Inc. | 2 | $42 |
Products named: REXULTI, VRAYLAR, Azstarys, CAPLYTA, Auvelity, Qelbree, FANAPT, SPRAVATO.
Industry payments across IA — which companies pay providers there.
